| 产品描述: | Elubrixin tosylate (SB-656933 tosylate) is a potent, selective, competitive, reversible and orally active CXCR2 antagonist and an IL-8 receptor antagonist. Elubrixin tosylate inhibits neutrophil CD11b upregulation (IC50 of 260.7 nM) and shape change (IC50 of 310.5 nM). Elubrixin tosylate has the potential for inflammatory diseases research, such as inflammatory bowel disease and airway inflammation. |
| 靶点: |
CXCR2;IL-8 |
| 体内研究: |
Elubrixin has an inhibitory effect on neutrophils in a dose-dependent fashion. |
| 保存条件: |
-80°C 12个月; -20°C 6个月, 干燥 |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
1.574 ml |
7.868 ml |
15.735 ml |
| 5 mM |
0.315 ml |
1.574 ml |
3.147 ml |
| 10 mM |
0.157 ml |
0.787 ml |
1.574 ml |
| 50 mM |
0.031 ml |
0.157 ml |
0.315 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |